India Pledges to Eradicate Hepatitis B and C by 2030
In a bold declaration at the United Nations General Assembly, India's Union Health Secretary Punya Salila Srivastava underscored the nation's commitment to eradicating Hepatitis B and C by 2030. This ambitious goal aligns with the World Health Assembly's call to eliminate viral hepatitis as a global health threat.
India's strategy is multifaceted, focusing on prevention, diagnosis, and treatment. The country's digital health infrastructure, bolstered by the Aadhaar system and initiatives like the Ayushman Bharat Digital Mission, provides a scalable platform for these efforts. This digital ecosystem facilitates antenatal screening and Hepatitis B immunisation, ensuring early detection and prevention.
Moreover, the government is enhancing safe blood transfusion services and offering extensive counselling and rehabilitation support for individuals who inject drugs. These interventions are crucial as they target the root causes of hepatitis transmission.
India's health authorities are also regulating drug use to mitigate associated health risks. By providing free diagnosis and treatment, the government aims to make healthcare accessible to all, irrespective of socio-economic status.
Global Health Implications
India's commitment is not just a domestic affair. The successful eradication of Hepatitis B and C would significantly impact global health, given India's population size and the potential for these efforts to serve as a blueprint for other nations.
Experts argue that India's approach could be instrumental in achieving the global targets set by the World Health Organisation. By prioritising prevention and leveraging technology, India could pave the way for a healthier future, free from the clutches of these persistent viral threats.
